Compare ALEMBIC with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs TTK HEALTHCARE - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC TTK HEALTHCARE ALEMBIC/
TTK HEALTHCARE
 
P/E (TTM) x 57.8 69.9 82.7% View Chart
P/BV x 5.0 1.7 285.5% View Chart
Dividend Yield % 0.2 0.9 23.1%  

Financials

 ALEMBIC   TTK HEALTHCARE
EQUITY SHARE DATA
    ALEMBIC
Mar-18
TTK HEALTHCARE
Mar-19
ALEMBIC/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs721,215 5.9%   
Low Rs34610 5.6%   
Sales per share (Unadj.) Rs4.7444.4 1.1%  
Earnings per share (Unadj.) Rs6.117.2 35.4%  
Cash flow per share (Unadj.) Rs6.227.6 22.6%  
Dividends per share (Unadj.) Rs0.205.00 4.0%  
Dividend yield (eoy) %0.40.5 68.9%  
Book value per share (Unadj.) Rs40.7177.9 22.9%  
Shares outstanding (eoy) m267.0314.13 1,889.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.32.1 548.5%   
Avg P/E ratio x8.752.9 16.4%  
P/CF ratio (eoy) x8.533.0 25.7%  
Price / Book Value ratio x1.35.1 25.4%  
Dividend payout %3.329.0 11.3%   
Avg Mkt Cap Rs m14,13912,894 109.7%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m2071,307 15.9%   
Avg. sales/employee Rs ThNM2,715.7-  
Avg. wages/employee Rs ThNM565.3-  
Avg. net profit/employee Rs ThNM105.4-  
INCOME DATA
Net Sales Rs m1,2556,279 20.0%  
Other income Rs m37078 477.7%   
Total revenues Rs m1,6256,356 25.6%   
Gross profit Rs m111496 22.4%  
Depreciation Rs m38147 25.8%   
Interest Rs m234 5.0%   
Profit before tax Rs m442393 112.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24149 16.1%   
Profit after tax Rs m1,630244 668.8%  
Gross profit margin %8.97.9 112.1%  
Effective tax rate %5.437.9 14.3%   
Net profit margin %129.83.9 3,345.5%  
BALANCE SHEET DATA
Current assets Rs m1,8672,717 68.7%   
Current liabilities Rs m5911,571 37.6%   
Net working cap to sales %101.618.3 556.7%  
Current ratio x3.21.7 182.6%  
Inventory Days Days9432 293.1%  
Debtors Days Days7447 157.6%  
Net fixed assets Rs m1,791991 180.7%   
Share capital Rs m534141 378.0%   
"Free" reserves Rs m10,3242,373 435.0%   
Net worth Rs m10,8582,514 431.8%   
Long term debt Rs m413 1,211.8%   
Total assets Rs m11,5914,158 278.7%  
Interest coverage x260.912.6 2,068.0%   
Debt to equity ratio x00 280.6%  
Sales to assets ratio x0.11.5 7.2%   
Return on assets %14.16.7 210.9%  
Return on equity %15.09.7 154.9%  
Return on capital %15.216.9 89.7%  
Exports to sales %1.53.6 43.1%   
Imports to sales %21.00.5 4,256.2%   
Exports (fob) Rs m19225 8.6%   
Imports (cif) Rs m26331 850.9%   
Fx inflow Rs m19225 8.6%   
Fx outflow Rs m26471 371.0%   
Net fx Rs m-244154 -158.6%   
CASH FLOW
From Operations Rs m236173 136.2%  
From Investments Rs m-22497 -232.1%  
From Financial Activity Rs m-27-307 8.7%  
Net Cashflow Rs m-15-38 39.3%  

Share Holding

Indian Promoters % 64.0 65.4 97.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 3.7 5.4%  
FIIs % 9.7 5.2 186.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 25.8 101.2%  
Shareholders   54,701 12,723 429.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare ALEMBIC With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Stove Kraft IPO, Key Q3FY21 Results, and Top Buzzing Stocks Today(Pre-Open)

On Friday, Indian share markets witnessed huge selling pressure and ended deep in the red, amid a global selloff.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jan 22, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS